Alpha 2.0
Login Register
» Authors » Britt-Marie Bernhardson

Britt-Marie Bernhardson

Explore the profile of Britt-Marie Bernhardson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 281
Followers 0
Related Specialties
Oncology
Nursing
General Medicine
Top 10 Co-Authors
Carol Tishelman
Ylva Orrevall
Lars E Eriksson
Kerstin Belqaid
Jenny McGreevy
Marlene Malmstrom
Eva Mansson-Brahme
Senada Hajdarevic
Lars Erik Rutqvist
Wendy Wismer
Published In
Eur J Oncol Nurs
Support Care Cancer
PLoS One
Evid Based Nurs
Scand J Caring Sci
Affiliations
Soon will be listed here.
Recent Articles
1.
Mistletoe Extract in Patients With Advanced Pancreatic Cancer: a Double-Blind, Randomized, Placebo-Controlled Tial (MISTRAL)
Wode K, Kienle G, Bjor O, Fransson P, Sharp L, Elander N, et al.
Dtsch Arztebl Int . 2024 Jun; 121(11):347-354. PMID: 38915151
Background: Patients with advanced pancreatic cancer have limited survival and few treatment options. We studied whether mistletoe extract (ME), in addition to comprehensive oncological treatment and palliative care, prolongs overall...
2.
Using patients' own knowledge of early sensations and symptoms to develop an interactive, individualized e-questionnaire to facilitate early diagnosis of lung cancer
Levitsky A, Bernhardson B, Henoch I, Olin M, Kolbeck K, Rystedt N, et al.
BMC Cancer . 2021 May; 21(1):544. PMID: 33985458
Background: One reason for the often late diagnosis of lung cancer (LC) may be that potentially-indicative sensations and symptoms are often diffuse, and may not be considered serious or urgent,...
3.
Sensations, symptoms, and then what? Early bodily experiences prior to diagnosis of lung cancer
Bernhardson B, Tishelman C, Rasmussen B, Hajdarevic S, Malmstrom M, Overgaard Hasle T, et al.
PLoS One . 2021 Mar; 16(3):e0249114. PMID: 33780498
Lung cancer (LC) generally lacks unique core symptoms or signs. However, there are a multitude of bodily sensations that are often non-specific, not easily understood, and many times initially not...
4.
Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)
Wode K, Nordberg J, Kienle G, Elander N, Bernhardson B, Sunde B, et al.
Trials . 2020 Sep; 21(1):783. PMID: 32917288
Background: Most pancreatic cancer patients present with advanced stage at diagnosis with extremely short expected survival and few treatment options. A multimodal palliative approach is necessary for symptom relief and...
5.
Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model
Levitsky A, Pernemalm M, Bernhardson B, Forshed J, Kolbeck K, Olin M, et al.
Sci Rep . 2019 Nov; 9(1):16504. PMID: 31712735
The aim of this study was to identify a combination of early predictive symptoms/sensations attributable to primary lung cancer (LC). An interactive e-questionnaire comprised of pre-diagnostic descriptors of first symptoms/sensations...
6.
It is important that the process goes quickly, isn't it?" A qualitative multi-country study of colorectal or lung cancer patients' narratives of the timeliness of diagnosis and quality of care
Malmstrom M, Rasmussen B, Bernhardson B, Hajdarevic S, Eriksson L, Sand Andersen R, et al.
Eur J Oncol Nurs . 2018 May; 34:82-88. PMID: 29784144
Purpose: The emphasis on early diagnosis to improve cancer survival has been a key factor in the development of cancer pathways across Europe. The aim of this analysis was to...
7.
Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer
Belqaid K, Tishelman C, Orrevall Y, Mansson-Brahme E, Bernhardson B
PLoS One . 2018 Jan; 13(1):e0191117. PMID: 29360871
Taste and smell alterations have been recognized as common symptoms in relation to various cancers. However, previous research suggests that patients do not receive sufficient support in managing taste and...
8.
Patients' initial steps to cancer diagnosis in Denmark, England and Sweden: what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors?
MacArtney J, Malmstrom M, Overgaard Nielsen T, Evans J, Bernhardson B, Hajdarevic S, et al.
BMJ Open . 2017 Nov; 7(11):e018210. PMID: 29151441
Objectives: To illuminate patterns observed in International Cancer Benchmarking Programme studies by extending understanding of the various influences on presentation and referral with cancer symptoms. Design: Cross-country comparison of Denmark,...
9.
A longitudinal study of changing characteristics of self-reported taste and smell alterations in patients treated for lung cancer
Belqaid K, Tishelman C, McGreevy J, Mansson-Brahme E, Orrevall Y, Wismer W, et al.
Eur J Oncol Nurs . 2015 Dec; 21:232-41. PMID: 26706824
Purpose: Taste and smell alterations (TSAs) are common symptoms in patients with cancer that may interfere with nutritional intake and quality of life. In this study, we explore and describe...
10.
Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer
McGreevy J, Orrevall Y, Belqaid K, Wismer W, Tishelman C, Bernhardson B
Support Care Cancer . 2014 Apr; 22(10):2635-44. PMID: 24752563
Purpose: Taste and smell alterations (TSAs) in patients with lung cancer are poorly understood. This study investigates characteristics of TSAs when most severe, reported by patients after starting treatment for...